Enhancing prescription drug innovation and adoption (Q33725286)

28 July 2017

title

Enhancing prescription drug innovation and adoption (English)

1 reference

28 July 2017

Alec B O'Connor

2

0 references

Randall S Stafford

object named as

Randall S Stafford

series ordinal

3

1 reference

ORCID Public Data File 2021

G Caleb Alexander

series ordinal

1

object named as

G Caleb Alexander

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 June 2011

1 reference

Annals of Internal Medicine

28 July 2017

published in

1 reference

28 July 2017

volume

154

1 reference

28 July 2017

issue

12

1 reference

28 July 2017

page(s)

833-7, W-301

1 reference

How Medicare Could Use Comparative Effectiveness Research In Deciding On New Coverage And Reimbursement

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4049188

Comparative effectiveness and health care spending--implications for reform

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4049188

Does comparative effectiveness have a comparative edge?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4049188

Sources of drug information: FDA-approved labeling and other official FDA sources

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4049188

The risk we bear: the effects of review speed and industry user fees on new drug safety

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4049188

Effects of torcetrapib in patients at high risk for coronary events

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4049188

Off-label prescribing among office-based physicians

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4049188

A comparative analysis of drug safety withdrawals in the UK and the US (1971-1992): implications for current regulatory thinking and policy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4049188

Back to thiazide-diuretics for hypertension: reflections after a decade of irrational prescribing

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4049188

Incentive-based formularies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4049188

Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4049188

Surrogate end points in clinical trials: are we being misled?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4049188

Surrogate endpoints in clinical trials: cardiovascular diseases.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4049188

Shattuck lecture. Innovation, regulation, and the FDA.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4049188

Using Market-Exclusivity Incentives to Promote Pharmaceutical Innovation

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4049188

New, but not improved? Incorporating comparative-effectiveness information into FDA labeling

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4049188

Promoting more conservative prescribing

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4049188

Using a drug facts box to communicate drug benefits and harms: two randomized trials

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4049188

Commercial features of placebo and therapeutic efficacy.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4049188

Do newer prescription drugs pay for themselves? A reassessment of the evidence

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4049188

Some factors to consider when using the results of economic evaluation studies at the population level.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4049188

A look back at 2000: overabundance and deregulation

30 October 2018

1 reference

12 December 2020

Industry funding of the FDA: effects of PDUFA on approval times and withdrawal rates

1 reference

12 December 2020

Do higher drug costs lead to better health?

1 reference

12 December 2020

How the US drug safety system should be changed

1 reference

12 December 2020

A proposal for radical changes in the drug-approval process

1 reference

12 December 2020

Medicaid's prior authorization program and access to atypical antipsychotic medications

1 reference

12 December 2020

Building Comparative Efficacy and Tolerability Into the FDA Approval Process

1 reference

12 December 2020

10.7326/0003-4819-154-12-201106210-00012

Identifiers

DOI

1 reference

28 July 2017

1 reference

28 July 2017

1 reference